Global Traumatic Brain Injuries (TBI) Treatment Market Size, Share, Forecast Report, 2020-2027

Global traumatic brain injuries treatment market is expected to rise steadily at a CAGR of 5.1% during forecast period of 2018–2023.

Traumatic brain injuries treatment (TBI) is an interruption in the normal function of the brain. It is a serious public health problem and is the leading cause of brain injury with at least 1.7 million people sustaining such injury every year. Traumatic brain injuries contribute to a substantial number of death and permanent disability every year. About 52,000 people dies of this injury which are commonly caused by car accident, falls, blunts force trauma, violent assaults and sporting injuries. An estimated 2.8 million people suffers from traumatic brain injuries treatment annually in United States of which 50,000 dies and 282,000 are hospitalized. Every day 153 people in United States die from TBI injury.

Numerous factors propelling the growth of this market are rising number of road traffic collisions and increasing number of aging populations. Whereas growing interests in research activities on diagnosis of TBI and new pipeline of drugs are further boosting the growth of traumatic brain injuries treatment market.

Despite the drivers, factors such as high cost of treatment and the use of monitoring devices may hinder the growth of market.

Segmentation:

Global traumatic brain injuries treatment market is further segmented into treatment types and end-users.

Based on treatment types the market is segmented into immediate emergency care, medications and surgery. On basis of medication global traumatic brain injuries treatment market is further sub-segmented into diuretics, anti-seizure drugs, coma-inducing drugs, anti-anxiety agent, anti-depressants, anti-psychotics, analgesic, anti-convulsant and anti-coagulants. Based on surgery, TBI market is further sub-segmented into removing clotted blood (hematomas), repairing skull fractures, bleeding in the brain, opening a window in the skull, rehabilitation.

On basis of end-users global traumatic brain injuries treatment market is further segmented into hospitals, neurologist, rehabilitative centre treatment, independent pharmacies and others.
Key players:

Some of the key players in the global traumatic brain injuries treatment market are Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc, TEVA Pharmaceutical Industries Ltd, Ischemic, Grace Laboratories LLC. Cognosci, Medicortex, Amarantus BioScience Holdings, Aldagen, NeuroScience Pharmaceuticals, Targacept. BioDirection, Inc., QuesGen Systems, Inc., BrainScope Company, Inc., Neural Analytics, Inc, Oculogica, BrainScope Company, Inc, Silver Creek, Pharmaceuticals Inc, Stemedica Cell Technologies Inc, Banayan Biomarkers Inc, Vasopharm GmbH, Zimmer Biomet.

Global Traumatic brain injuries treatment Market, by Treatment

• Immediate emergency care
• Medications
  • Diuretics
  • Anti-seizure drugs
  • Coma-inducing drugs
  • Anti-anxiety agent
  • Anti-depressants
  • Anti-psychotics
  • Analgesic
  • Anti-convulsant
  • Anti-coagulants
• Surgery
  • Removing clotted blood (hematomas)
  • Repairing skull fractures
  • Bleeding in the brain
  • Opening a window in the skull
  • Rehabilitation

Global Traumatic brain injuries treatment Market, by End User

• Hospitals
• Neurologist
• Independent pharmacies
• Rehabilitative centre treatment
• Other